This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Genfit. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Pascal Birman
Introduction
Pascal Birman is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of primary biliary cholangitis (PBC). His work has the potential to improve the lives of many patients who are intolerant to traditional treatments.
Latest Patents
Pascal Birman holds a patent for "Compositions and methods for the treatment of primary biliary cholangitis." This invention relates to a pharmaceutical composition comprising elafibranor or a pharmaceutically acceptable salt thereof, specifically designed for use in treating PBC in subjects who cannot tolerate ursodeoxycholic acid (UDCA). He has 1 patent to his name.
Career Highlights
Birman is currently associated with Genfit, a company focused on developing innovative therapies for liver diseases. His role at Genfit has allowed him to work on groundbreaking research that addresses unmet medical needs in the field of hepatology.
Collaborations
Throughout his career, Pascal has collaborated with talented individuals such as Alice Roudot and David Magrez. These partnerships have fostered a creative environment that encourages the development of new ideas and solutions in the pharmaceutical industry.
Conclusion
Pascal Birman is a distinguished inventor whose work in the treatment of primary biliary cholangitis showcases his commitment to advancing medical science. His contributions are paving the way for better treatment options for patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile